Philip Morris seeks authorization to sell new product in the US

According to a report from MarketWatch on the 20th, American tobacco giant Philip Morris International has recently submitted an important application to the U.S. Food and Drug Administration to introduce its new tobacco product, IQOS Iluma, to the U.S. market.

This application includes a "premarket tobacco product application" and a "modified risk tobacco product application." The former is necessary before selling new tobacco products in the U.S., while the latter ensures that the new product can reduce exposure to harmful chemicals.

The IQOS Iluma product operates on an unusual principle, providing a tobacco experience by heating tobacco rather than burning it. This technology is an evolution of IQOS, which has already received sales authorization in some international markets.

Philip Morris stated that the IQOS Iluma product is currently available in 27 markets worldwide, and this application marks its active pursuit of entry into the U.S. market.